Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

5-Aminoisoquinolin-1-one (5-AIQ), a Water-Soluble Inhibitor of the Poly¬(ADP Ribose)¬Polymerases (PARPs).
A systems pharmacology approach to decipher the mechanism of danggui-shaoyao-san decoction for the treatment of neurodegenerative diseases.
Regulation of Immunity by Butyrophilins.
Both endoplasmic reticulum and mitochondrial pathways are involved in oligodendrocyte apoptosis induced by capsular hemorrhage.
Teriflunomide: A Once-Daily Oral Medication for the Treatment of Relapsing Forms of Multiple Sclerosis.
Genetic manipulation of microglia during brain development and disease.
Elevation of 20-carbon long chain bases due to a mutation in serine palmitoyltransferase small subunit b results in neurodegeneration.
Anti-inflammatory effects of the cannabidiol derivative dimethylheptyl-cannabidiol - studies in BV-2 microglia and encephalitogenic T cells.
An unusual presentation of X-linked adrenoleukodystrophy.
An aza-anthrapyrazole negatively regulates Th1 activity and suppresses experimental autoimmune encephalomyelitis.
Astragaloside IV inhibits microglia activation via glucocorticoid receptor mediated signaling pathway.
Is it necessary to perform connective tissue disorders laboratory tests when a patient experiences the first demyelinating attack?
Neuromyelitis optica spectrum disorder in a patient with Kikuchi-Fujimoto disease.
Metformin ameliorates the development of experimental autoimmune encephalomyelitis by regulating T helper 17 and regulatory T cells in mice.
Should a psychotic or manic episode be considered an early manifestation of Multiple Sclerosis? A multiple case study.
Granzyme B-inhibitor serpina3n induces neuroprotection in vitro and in vivo.
Eomesodermin-expressing T-helper cells are essential for chronic neuroinflammation.
Genetic, Immune-Inflammatory, and Oxidative Stress Biomarkers as Predictors for Disability and Disease Progression in Multiple Sclerosis.
Cortical Thinning Correlates with Cognitive Change in Multiple Sclerosis but not in Neuromyelitis Optica.
Does Natalizumab Therapy Benefit Patients With Multiple Sclerosis?
Role of phospholipase A(2)s and lipid mediators in secondary damage after spinal cord injury.
Animal modeling an oligodendrogliopathy - multiple system atrophy.
A Preliminary Comparative Assessment of the Role of CD8+ T Cells in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis and Multiple Sclerosis.
Post-acute serum eosinophil and neutrophil-associated cytokine/chemokine profile can distinguish between patients with neuromyelitis optica and multiple sclerosis; and identifies potential pathophysiological mechanisms - A pilot study.
Neurovascular unit dysfunction with blood-brain barrier hyperpermeability contributes to major depressive disorder: a review of clinical and experimental evidence.

Pages